Lactobacillus rhamnosus GG and Bifidobacterium longum attenuate lung injury and inflammatory response in experimental sepsis

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Khailova, Ludmila ^a   Petrie, Benjamin ^a   Baird, Christine H ^a   Dominguez Rieg, Jessica A ^a   Wischmeyer, Paul E ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MESSENGER RNA; MYELOID DIFFERENTIATION FACTOR 88; PROBIOTIC AGENT; STERILE WATER; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; PTGS2 PROTEIN, MOUSE; TOLL LIKE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERIAL STRAIN; BIFIDOBACTERIUM LONGUM; CONTROLLED STUDY; DRUG EFFICACY; GENE EXPRESSION REGULATION; LACTOBACILLUS RHAMNOSUS; LUNG INJURY; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; OUTCOME ASSESSMENT; PERITONITIS; PNEUMONIA; SEPSIS; ANIMAL; BIFIDOBACTERIUM; COMPLICATION; IMMUNOLOGY; METABOLISM; MICROBIOLOGY;

ANIMALS; BIFIDOBACTERIUM; CYCLOOXYGENASE 2; INTERLEUKIN-6; LACTOBACILLUS RHAMNOSUS; LUNG INJURY; MICE; NEUTROPHIL INFILTRATION; PNEUMONIA; PROBIOTICS; SEPSIS; TOLL-LIKE RECEPTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84901307371     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0097861     Document Type: Article

References (77)

1. Watson RS, Carcillo JA, Linde-Zwirble WT, Clermont G, Lidicker J, et al. (2003) The epidemiology of severe sepsis in children in the United States. Am J Respir Crit Care Med 167: 695-701. (Pubitemid 36801744)
2. Lukacs SL, Schoendorf KC, Schuchat A (2004) Trends in sepsis-related neonatal mortality in the United States, 1985-1998. Pediatr Infect Dis J 23: 599-603. (Pubitemid 38924881)
3. Wynn JL, Scumpia PO, Delano MJ, O'Malley KA, Ungaro R, et al. (2007) Increased mortality and altered immunity in neonatal sepsis produced by generalized peritonitis. Shock 28: 675-683. (Pubitemid 350135472)
4. Kermorvant-Duchemin E, Laborie S, Rabilloud M, Lapillonne A, Claris O (2008) Outcome and prognostic factors in neonates with septic shock. Pediatr Crit Care Med 9: 186-191. (Pubitemid 351355023)
5. Adams-Chapman I, Stoll BJ (2006) Neonatal infection and long-term neurodevelopmental outcome in the preterm infant. Curr Opin Infect Dis 19: 290-297. (Pubitemid 43740369)
6. Dahlem P, van Aalderen WM, Bos AP (2007) Pediatric acute lung injury. Paediatr Respir Rev 8: 348-362. (Pubitemid 350102999)
7. Flori HR, Glidden DV, Rutherford GW, Matthay MA (2005) Pediatric acute lung injury: prospective evaluation of risk factors associated with mortality. Am J Respir Crit Care Med 171: 995-1001. (Pubitemid 40616948)
8. Singhi SC, Baranwal A (2008) Probiotic use in the critically ill. Indian J Pediatr 75: 621-627.
9. Hammerman C, Bin-Nun A, Kaplan M (2004) Germ warfare: probiotics in defense of the premature gut. Clin Perinatol 31: 489-500. (Pubitemid 39119481)
10. Hojsak I, Abdovic S, Szajewska H, Milosevic M, Krznaric Z, et al. (2010) Lactobacillus GG in the prevention of nosocomial gastrointestinal and respiratory tract infections. Pediatrics 125: e1171-1177.
11. Morrow LE, Kollef MH, Casale TB (2010) Probiotic prophylaxis of ventilator-associated pneumonia: a blinded, randomized, controlled trial. Am J Respir Crit Care Med 182: 1058-1064.
12. Siempos, II, Ntaidou TK, Falagas ME (2010) Impact of the administration of probiotics on the incidence of ventilator-associated pneumonia: a meta-analysis of randomized controlled trials. Crit Care Med 38: 954-962.
13. Pitsouni E, Alexiou V, Saridakis V, Peppas G, Falagas ME (2009) Does the use of probiotics/synbiotics prevent postoperative infections in patients undergoing abdominal surgery? A meta-analysis of randomized controlled trials. Eur J Clin Pharmacol 65: 561-570.
14. Bausserman M, Michail S (2005) The use of Lactobacillus GG in irritable bowel syndrome in children: a double-blind randomized control trial. J Pediatr 147: 197-201. (Pubitemid 41207833)
15. Bin-Nun A, Bromiker R, Wilschanski M, Kaplan M, Rudensky B, et al. (2005) Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates. J Pediatr 147: 192-196. (Pubitemid 41207832)
16. Drouault-Holowacz S, Bieuvelet S, Burckel A, Cazaubiel M, Dray X, et al. (2008) A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome. Gastroenterol Clin Biol 32: 147-152. (Pubitemid 351637577)
17. Arvola T, Laiho K, Torkkeli S, Mykkanen H, Salminen S, et al. (1999) Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhea in children with respiratory infections: a randomized study. Pediatrics 104: e64.
18. Olah A, Belagyi T, Poto L, Romics L Jr, Bengmark S (2007) Synbiotic control of inflammation and infection in severe acute pancreatitis: a prospective, randomized, double blind study. Hepatogastroenterology 54: 590-594. (Pubitemid 46724735)
19. Schultz MJ (2010) Symbiotics as a preventive measure against ventilator-associated pneumonia. Crit Care Med 38: 1506-1507; author reply 1507.
20. Giamarellos-Bourboulis EJ, Bengmark S, Kanellakopoulou K, Kotzampassi K (2009) Pro- and synbiotics to control inflammation and infection in patients with multiple injuries. J Trauma 67: 815-821.
21. Kotzampassi K, Giamarellos-Bourboulis EJ, Voudouris A, Kazamias P, Eleftheriadis E (2006) Benefits of a synbiotic formula (Synbiotic 2000Forte) in critically Ill trauma patients: early results of a randomized controlled trial. World J Surg 30: 1848-1855. (Pubitemid 44454998)
22. Shanahan F (2002) Probiotics and inflammatory bowel disease: from fads and fantasy to facts and future. Br J Nutr 88 Suppl 1: S5-9.
23. Khailova L, Mount Patrick SK, Arganbright KM, Halpern MD, Kinouchi T, et al. (2010) Bifidobacterium bifidum reduces apoptosis in the intestinal epithelium in necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol 299: G1118-1127.
24. Tao Y, Drabik KA, Waypa TS, Musch MW, Alverdy JC, et al. (2006) Soluble factors from Lactobacillus GG activate MAPKs and induce cytoprotective heat shock proteins in intestinal epithelial cells. Am J Physiol Cell Physiol 290: C1018-1030.
25. Yan F, Cao H, Cover TL, Whitehead R, Washington MK, et al. (2007) Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth. Gastroenterology 132: 562-575. (Pubitemid 46274659)
26. Yan F, Polk DB (2002) Probiotic bacterium prevents cytokine-induced apoptosis in intestinal epithelial cells. J Biol Chem 277: 50959-50965. (Pubitemid 36042264)
27. Alberda C, Gramlich L, Meddings J, Field C, McCargar L, et al. (2007) Effects of probiotic therapy in critically ill patients: a randomized, double-blind, placebo-controlled trial. Am J Clin Nutr 85: 816-823. (Pubitemid 46393515)
28. Anderson RC, Cookson AL, McNabb WC, Kelly WJ, Roy NC (2010) Lactobacillus plantarum DSM 2648 is a potential probiotic that enhances intestinal barrier function. FEMS Microbiol Lett 309: 184-192.
29. Khailova L, Dvorak K, Arganbright KM, Halpern MD, Kinouchi T, et al. (2009) Bifidobacterium bifidum improves intestinal integrity in a rat model of necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol 297: G940-949.
30. Zareie M, Johnson-Henry K, Jury J, Yang PC, Ngan BY, et al. (2006) Probiotics prevent bacterial translocation and improve intestinal barrier function in rats following chronic psychological stress. Gut 55: 1553-1560. (Pubitemid 44629200)
31. Luyer MD, Buurman WA, Hadfoune M, Speelmans G, Knol J, et al. (2005) Strain-specific effects of probiotics on gut barrier integrity following hemorrhagic shock. Infect Immun 73: 3686-3692. (Pubitemid 40745913)
32. Aguero G, Villena J, Racedo S, Haro C, Alvarez S (2006) Beneficial immunomodulatory activity of Lactobacillus casei in malnourished mice pneumonia: effect on inflammation and coagulation. Nutrition 22: 810-819. (Pubitemid 43947497)
33. Arribas B, Rodriguez-Cabezas ME, Comalada M, Bailon E, Camuesco D, et al. (2009) Evaluation of the preventative effects exerted by Lactobacillus fermentum in an experimental model of septic shock induced in mice. Br J Nutr 101: 51-58. (Pubitemid 352795581)
34. Matsumoto T, Ishikawa H, Tateda K, Yaeshima T, Ishibashi N, et al. (2008) Oral administration of Bifidobacterium longum prevents gut-derived Pseudomonas aeruginosa sepsis in mice. J Appl Microbiol 104: 672-680. (Pubitemid 351257734)
35. Tok D, Ilkgul O, Bengmark S, Aydede H, Erhan Y, et al. (2007) Pretreatment with pro- and synbiotics reduces peritonitis-induced acute lung injury in rats. J Trauma 62: 880-885. (Pubitemid 46624204)
36. Khailova L, Frank DN, Dominguez JA, Wischmeyer PE (2013) Probiotic Administration Reduces Mortality and Improves Intestinal Epithelial Homeostasis in Experimental Sepsis. Anesthesiology.
37. Annane D, Bellissant E, Cavaillon JM (2005) Septic shock. Lancet 365: 63-78.
38. Akira S, Uematsu S, Takeuchi O (2006) Pathogen recognition and innate immunity. Cell 124: 783-801. (Pubitemid 43261452)
39. Xu F, Xu Z, Zhang R, Wu Z, Lim JH, et al. (2008) Nontypeable Haemophilus influenzae induces COX-2 and PGE2 expression in lung epithelial cells via activation of p38 MAPK and NF-kappa B. Respir Res 9: 16.
40. Kirkby NS, Zaiss AK, Wright WR, Jiao J, Chan MV, et al. (2013) Differential COX-2 induction by viral and bacterial PAMPs: Consequences for cytokine and interferon responses and implications for anti-viral COX-2 directed therapies. Biochem Biophys Res Commun 438: 249-256.
41. Baker CC, Chaudry IH, Gaines HO, Baue AE (1983) Evaluation of factors affecting mortality rate after sepsis in a murine cecal ligation and puncture model. Surgery 94: 331-335. (Pubitemid 13043132)
42. Robertson CM, Perrone EE, McConnell KW, Dunne WM, Boody B, et al. (2008) Neutrophil depletion causes a fatal defect in murine pulmonary Staphylococcus aureus clearance. J Surg Res 150: 278-285.
43. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408. (Pubitemid 34164012)
44. Hajjar AM, Harowicz H, Liggitt HD, Fink PJ, Wilson CB, et al. (2005) An essential role for non-bone marrow-derived cells in control of Pseudomonas aeruginosa pneumonia. Am J Respir Cell Mol Biol 33: 470-475. (Pubitemid 41572690)
45. MacFie J, O'Boyle C, Mitchell CJ, Buckley PM, Johnstone D, et al. (1999) Gut origin of sepsis: a prospective study investigating associations between bacterial translocation, gastric microflora, and septic morbidity. Gut 45: 223-228. (Pubitemid 29333771)
46. Wang X, Andersson R, Soltesz V, Leveau P, Ihse I (1996) Gut origin sepsis, macrophage function, and oxygen extraction associated with acute pancreatitis in the rat. World J Surg 20: 299-307; discussion 307-298.
47. Cleveland J, Montville TJ, Nes IF, Chikindas ML (2001) Bacteriocins: safe, natural antimicrobials for food preservation. Int J Food Microbiol 71: 1-20. (Pubitemid 33065596)
48. Lee YK, Lim CY, Teng WL, Ouwehand AC, Tuomola EM, et al. (2000) Quantitative approach in the study of adhesion of lactic acid bacteria to intestinal cells and their competition with enterobacteria. Appl Environ Microbiol 66: 3692-3697.
49. Yan F, Cao H, Cover TL, Washington MK, Shi Y, et al. (2011) Colon-specific delivery of a probiotic-derived soluble protein ameliorates intestinal inflammation in mice through an EGFR-dependent mechanism. J Clin Invest 121: 2242-2253.
50. Harb H, van Tol EA, Heine H, Braaksma M, Gross G, et al. (2013) Neonatal supplementation of processed supernatant from Lactobacillus rhamnosus GG improves allergic airway inflammation in mice later in life. Clin Exp Allergy 43: 353-364.
51. Yan F, Polk DB (2012) Characterization of a probiotic-derived soluble protein which reveals a mechanism of preventive and treatment effects of probiotics on intestinal inflammatory diseases. Gut Microbes 3: 25-28.
52. van Baarlen P, Troost F, van der Meer C, Hooiveld G, Boekschoten M, et al. (2011) Human mucosal in vivo transcriptome responses to three lactobacilli indicate how probiotics may modulate human cellular pathways. Proc Natl Acad Sci U S A 108 Suppl 1: 4562-4569.
53. Ashraf R, Shah NP (2014) Immune system stimulation by probiotic microorganisms. Crit Rev Food Sci Nutr 54: 938-956.
54. Dani C, Biadaioli R, Bertini G, Martelli E, Rubaltelli FF (2002) Probiotics feeding in prevention of urinary tract infection, bacterial sepsis and necrotizing enterocolitis in preterm infants. A prospective double-blind study. Biol Neonate 82: 103-108.
55. McNaught CE, Woodcock NP, Anderson AD, MacFie J (2005) A prospective randomised trial of probiotics in critically ill patients. Clin Nutr 24: 211-219. (Pubitemid 40392804)
56. Honeycutt TC, El Khashab M, Wardrop RM 3rd, McNeal-Trice K, Honeycutt AL, et al. (2007) Probiotic administration and the incidence of nosocomial infection in pediatric intensive care: a randomized placebo-controlled trial. Pediatr Crit Care Med 8: 452-458; quiz 464.
57. Netea MG, van der Meer JW, van Deuren M, Kullberg BJ (2003) Proinflammatory cytokines and sepsis syndrome: not enough, or too much of a good thing? Trends Immunol 24: 254-258. (Pubitemid 36555964)
58. Kono Y, Inomata M, Hagiwara S, Shiraishi N, Noguchi T, et al. (2011) A newly synthetic vitamin E derivative, E-Ant-S-GS, attenuates lung injury caused by cecal ligation and puncture-induced sepsis in rats. Surgery.
59. Williams DL, Ha T, Li C, Kalbfleisch JH, Laffan JJ, et al. (1999) Inhibiting early zactivation of tissue nuclear factor-kappa B and nuclear factor interleukin 6 with (1→3)-beta-D-glucan increases long-term survival in polymicrobial sepsis. Surgery 126: 54-65. (Pubitemid 29340692)
60. Regel G, Grotz M, Weltner T, Sturm JA, Tscherne H (1996) Pattern of organ failure following severe trauma. World J Surg 20: 422-429. (Pubitemid 26138589)
61. Farley KS, Wang LF, Razavi HM, Law C, Rohan M, et al. (2006) Effects of macrophage inducible nitric oxide synthase in murine septic lung injury. Am J Physiol Lung Cell Mol Physiol 290: L1164-1172. (Pubitemid 43830861)
62. Singleton KD, Wischmeyer PE (2007) Glutamine's protection against sepsis and lung injury is dependent on heat shock protein 70 expression. Am J Physiol Regul Integr Comp Physiol 292: R1839-1845. (Pubitemid 46708539)
63. Racedo S, Villena J, Medina M, Aguero G, Rodriguez V, et al. (2006) Lactobacillus casei administration reduces lung injuries in a Streptococcus pneumoniae infection in mice. Microbes Infect 8: 2359-2366. (Pubitemid 44499044)
64. Appleby SB, Ristimaki A, Neilson K, Narko K, Hla T (1994) Structure of the human cyclo-oxygenase-2 gene. Biochem J 302 (Pt 3): 723-727. (Pubitemid 24289307)
65. Rajapakse N, Kim MM, Mendis E, Kim SK (2008) Inhibition of inducible nitric oxide synthase and cyclooxygenase-2 in lipopolysaccharide-stimulated RAW264.7 cells by carboxybutyrylated glucosamine takes place via downregulation of mitogen-activated protein kinase-mediated nuclear factor-kappaB signaling. Immunology 123: 348-357. (Pubitemid 351171187)
66. Zhang LN, Zheng JJ, Zhang L, Gong X, Huang H, et al. (2011) Protective effects of asiaticoside on septic lung injury in mice. Exp Toxicol Pathol 63: 519-525.
67. Li XH, Gong X, Zhang L, Jiang R, Li HZ, et al. (2013) Protective effects of polydatin on septic lung injury in mice via upregulation of HO-1. Mediators Inflamm 2013: 354087.
68. Ang SF, Sio SW, Moochhala SM, MacAry PA, Bhatia M (2011) Hydrogen sulfide upregulates cyclooxygenase-2 and prostaglandin E metabolite in sepsis-evoked acute lung injury via transient receptor potential vanilloid type 1 channel activation. J Immunol 187: 4778-4787.
69. Bitto A, Minutoli L, David A, Irrera N, Rinaldi M, et al. (2012) Flavocoxid, a dual inhibitor of COX-2 and 5-LOX of natural origin, attenuates the inflammatory response and protects mice from sepsis. Crit Care 16: R32.
70. Akira S, Takeda K (2004) Toll-like receptor signalling. Nat Rev Immunol 4: 499-511. (Pubitemid 38931765)
71. Tsujimoto H, Ono S, Hiraki S, Majima T, Kawarabayashi N, et al. (2004) Hemoperfusion with polymyxin B-immobilized fibers reduced the number of CD16+ CD14+ monocytes in patients with septic shock. J Endotoxin Res 10: 229-237. (Pubitemid 39481012)
72. Armstrong L, Medford AR, Hunter KJ, Uppington KM, Millar AB (2004) Differential expression of Toll-like receptor (TLR)-2 and TLR-4 on monocytes in human sepsis. Clin Exp Immunol 136: 312-319. (Pubitemid 38543451)
73. Harter L, Mica L, Stocker R, Trentz O, Keel M (2004) Increased expression of toll-like receptor-2 and -4 on leukocytes from patients with sepsis. Shock 22: 403-409. (Pubitemid 39472563)
74. Tsujimoto H, Ono S, Majima T, Kawarabayashi N, Takayama E, et al. (2005) Neutrophil elastase, MIP-2, and TLR-4 expression during human and experimental sepsis. Shock 23: 39-44. (Pubitemid 40083026)
75. Williams DL, Ha T, Li C, Kalbfleisch JH, Schweitzer J, et al. (2003) Modulation of tissue Toll-like receptor 2 and 4 during the early phases of polymicrobial sepsis correlates with mortality. Crit Care Med 31: 1808-1818. (Pubitemid 36714241)
76. Edelman DA, Jiang Y, Tyburski J, Wilson RF, Steffes C (2006) Toll-like receptor-4 message is up-regulated in lipopolysaccharide-exposed rat lung pericytes. J Surg Res 134: 22-27. (Pubitemid 43866826)
77. Yu M, Shao D, Liu J, Zhu J, Zhang Z, et al. (2007) Effects of ketamine on levels of cytokines, NF-kappaB and TLRs in rat intestine during CLP-induced sepsis. Int Immunopharmacol 7: 1076-1082. (Pubitemid 46891327)